# US 2016/0250070 A1 · Apparatuses, tools and kits relating to fluid manipulation treatments of paranasal sinuses

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0250070 A1
- Document ID: US20160250070A1
- Status: Published application
- Kind: A1
- Application number: 15/027,406
- Filed: 2014-10-16
- Published: 2016-09-01
- Earliest claimed: 2013-10-16
- Assignees: Sinopsys Surgical, Inc.
- Applicants: Sinopsys Surgical, Inc.
- Inventors: Brian James WILLOUGHBY; Christopher Lee OLIVER; Harry ROSS; William W. CIMINO
- Web page: https://patentgrep.com/patent/US20160250070A1

## CPC

- A61F 9/00772: {Apparatus for restoration of tear ducts}
- A61M 2210/0618: Nose
- A61M 2210/0681: Sinus (maxillaris)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Apparatuses, tools and kits are directed to fluid manipulations in relation to a paranasal sinus through a paranasal sinus access implant device (906) that provides fluid communication between the lacrimal apparatus in the orbit and a paranasal sinus. An implant device has a proximal head and a conduit distal of the head, with the conduit having a first longitudinal portion having a larger minimum wall thickness than a minimum wall thickness of a second a second longitudinal portion of the conduit located distal of the first longitudinal portion. A paranasal sinus fluid manipulation tool (900) has an engagement structure (904) insertable into the palpebral fissure to engage a head of the implant device.

## Claims

### Claim 1

A paranasal sinus fluid treatment apparatus, comprising:
a paranasal sinus access implant device configured to be implanted in a human to provide fluid access to a paranasal sinus, the paranasal sinus access implant device comprising:
a head configured to be disposed between the medial canthus and the medial side of an adjacent eyeball when the paranasal sinus access implant device is implanted; and
an internal passage providing fluid access through the paranasal sinus access implant device to a paranasal sinus when the paranasal sinus access implant device is implanted, the internal passage being accessible through an opening in the head;
a paranasal sinus fluid manipulation tool, the paranasal sinus fluid manipulation tool comprising:
a fluid container;
a paranasal sinus fluid connection engagement structure in engagement with the head to fluidly connect the paranasal sinus fluid manipulation tool with the paranasal sinus access implant device, the paranasal sinus fluid connection engagement structure being configured to be disposed in the palpebral fissure;
a fluid transmission structure configured to transmit fluid between the fluid container and the paranasal sinus access implant device; and
the paranasal sinus fluid manipulation tool being manipulable to perform at least one of the following fluid manipulations when the paranasal sinus access implant device is implanted to provide fluid access to a paranasal sinus: (i) introduction of fluid from the fluid container into the internal passage for delivery to a paranasal sinus and (ii) applying suction to the internal passage for aspiration of fluid from a paranasal sinus through the internal passage.

### Claim 2 (depends on 1)

An apparatus according to claim 1, wherein:
the paranasal sinus fluid connection engagement structure has an insertion cross-section positionable within a first rectangular area having a first length dimension no larger than 12 millimeters and a first width dimension no larger than 8 millimeters; and
the insertion cross-section is not positionable in a second rectangular area having a second length dimension of at least 3 millimeters and no larger than the first length dimension and having a second width dimension of at least 1.5 millimeters and smaller than the first width dimension.

### Claim 3 (depends on 1, 2)

An apparatus according to either one of claim 1 or claim 2, wherein the insertion cross-section has an aspect ratio of length to width of at least 1.5:1.

### Claim 4 (depends on 1, 2, 3)

An apparatus according to any one of claims 1-3, wherein the paranasal sinus fluid connection engagement structure comprises a receptacle for receiving the head when in the engagement;
the receptacle includes a stop that limits a depth within the receptacle to which the head is receivable in the receptacle in the engagement to no more than 5 millimeters; and
the receptacle has a receiving geometry that is keyed to align with a corresponding geometry of the periphery of the head.

### Claim 5 (depends on 4)

An apparatus according to claim 4, wherein in the engagement clearance fit of the head in the receptacle is no larger than 0.25 millimeter.

### Claim 6 (depends on 4, 5)

An apparatus according to either one of claim 4 or claim 5, wherein the receptacle has an oval geometry and the head has a mating oval geometry received within the receptacle in the engagement.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

An apparatus according to any one of claims 1-6, wherein the paranasal sinus fluid connection engagement structure comprises an insertion stub inserted through the opening into the internal passage in the engagement.

### Claim 8 (depends on 7)

An apparatus according to claim 7, wherein in the engagement the insertion stub does not extend beyond a distal end of the internal passage.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

An apparatus according to any one of claims 1-8, wherein in the engagement the paranasal sinus fluid connection engagement structure and the head are in surface contact around the entire periphery of the opening.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

An apparatus according to any one of claims 1-9, wherein in the engagement the paranasal sinus fluid connection engagement structure and the head contact to form a fluid seal therebetween.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

An apparatus according to any one of claims 1-10, wherein in the engagement no portion of the paranasal sinus fluid manipulation tool extends through the opening in the head.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

An apparatus according to any one of claims 1-11, wherein in the engagement at least a portion of the paranasal sinus fluid manipulation tool is disposed exterior to the paranasal sinus access implant device and distal to a proximal end of the paranasal sinus access implant device.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

An apparatus according to any one of claims 1-12, wherein the fluid container comprises at least a portion of a barrel of a syringe, the syringe including a piston disposed within the barrel that is manipulable to manipulate fluid in the fluid container.

### Claim 14 (depends on 13)

An apparatus according to claim 13, wherein the paranasal sinus fluid connection engagement structure is on a distal portion of a fluid transmission attachment connected with the syringe; and
the fluid transmission structure comprises a fluid conduit in fluid communication with the fluid container and the internal passage.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

An apparatus according to any one of claims 1-14, comprising a fluid treatment composition disposed within the fluid container.

### Claim 16 (depends on 15)

An apparatus according to claim 15, wherein the treatment composition is an aqueous irrigation liquid.

### Claim 17 (depends on 15)

An apparatus according to claim 15, wherein the treatment composition is a drug treatment composition.

### Claim 18 (depends on 17)

An apparatus according to claim 17, wherein the drug treatment composition comprises at least one drug for treating sinusitis.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

An apparatus according to any one of claims 1-18, wherein the paranasal sinus access implant device comprises:
a proximal end at a first longitudinal end, the head being adjacent the proximal end;
a distal end at a second longitudinal end that is longitudinally opposite the first longitudinal end;
a conduit disposed between the head and the distal end, the internal passage extending through the head and the conduit;
a length longitudinally along the paranasal sinus access implant device between the proximal end and the distal end in a range of from 2 millimeters to 50 millimeters;
a width of the internal passage transverse to the length of the paranasal sinus access implant device in a range of from 0.25 millimeter to 5 millimeters;
the conduit includes a first longitudinal portion and a second longitudinal portion located toward the distal end relative to the first longitudinal portion;
the first longitudinal portion of the conduit has a first minimum wall thickness adjacent the internal passage;
the second longitudinal portion of the conduit has a second minimum wall thickness adjacent the internal passage that is smaller than the first minimum wall thickness; and
the paranasal sinus access implant device is configured to be implanted between the lacrimal apparatus in the orbit and a paranasal sinus, wherein when so implanted at least a portion of each of the first longitudinal portion and the second longitudinal portion of the conduit are disposed across tissue between the lacrimal apparatus in the orbit and the paranasal sinus and at least a portion of the second longitudinal portion of the conduit is disposed in the paranasal sinus.

### Claim 20 (depends on 19)

A subject matter according to claim 19, wherein the first longitudinal portion of the conduit has a length in a range of from 5 millimeters to 15 millimeters; and
the first minimum wall thickness is at least 0.35 millimeter and is at least 0.05 millimeter larger than the second minimum wall thickness.

### Claim 21 (depends on 19, 20)

An apparatus according to either one of claim 19 or claim 20, wherein the second longitudinal portion of the conduit has a length in a range of from 5 millimeters to 15 millimeters.

### Claim 22 (depends on 19, 20, 21)

An apparatus according to any one of claims 19-21, wherein the first longitudinal portion of the conduit has a first maximum exterior width that is smaller than a second maximum exterior width of the second longitudinal portion of the conduit;
the second maximum exterior width is at least 0.2 millimeters larger than the first maximum exterior width;
the first maximum exterior width is in a range of from 1.5 millimeters to 2.5 millimeters;
the first longitudinal portion of the conduit has a first minimum exterior width and the second longitudinal portion of the conduit has a second minimum exterior width;
the second minimum exterior width is smaller than the first maximum exterior width;
the first minimum exterior width is larger than the second minimum exterior width;
the first maximum exterior width and the first minimum exterior width are each within a range of from 1.5 millimeters to 2.5 millimeters;
the second maximum exterior width is in a range of from 1.6 millimeters to 3 millimeters;
the second minimum exterior width is in a range of from 1 millimeter to 2 millimeters;
the first minimum exterior width is at least 0.1 millimeter larger than the second minimum exterior width; and
the second maximum exterior width is at least 0.2 millimeter larger than the first maximum exterior width.

### Claim 23 (depends on 19, 20, 21, 22)

An apparatus according to any one of claims 19-22, wherein an exterior of the second longitudinal portion of the conduit includes an anchoring surface feature including protrusion areas and recess areas;
the protrusion areas are on a longitudinal portion of the second longitudinal portion of the conduit extending at least 5 millimeters along the length of the device; and
the first longitudinal portion of the conduit is in the absence of the anchoring surface feature.

### Claim 24 (depends on 1)

An apparatus according to claim 1, wherein:
the paranasal sinus fluid connection engagement structure has an insertion cross-section having an aspect ratio of length to width of at least 1.5, being positionable within a first rectangular area having a first length dimension of 12 millimeters and a first width dimension of 8 millimeters, and being not positionable within a second rectangular area having a second length dimension of 5 millimeters and a second width dimension of 2 millimeters;
the paranasal sinus fluid connection engagement structure comprises a receptacle for receiving the head;
the receptacle includes a stop that limits a depth within the receptacle to which the head is receivable in the receptacle to no more than 5 millimeters in the engagement;
the receptacle has a receiving geometry that is keyed to align with a corresponding geometry of the periphery of the head in the engagement; and
in the engagement the paranasal sinus fluid connection engagement structure and the head are in flush surface contact around the entire periphery of the opening.

### Claim 25 (depends on 24)

An apparatus according to claim 24, wherein the paranasal sinus access implant device comprises a conduit adjacent the head;
the head comprises a flanged tissue engagement surface on a side of the head disposed toward the conduit and configured to engage tissue when the paranasal sinus access implant device is implanted;
the flanged tissue engagement surface comprises an outer edge;
the head has a first dimension that is a maximum separation distance between points on the outer edge of the flanged tissue engagement surface, the first dimension being larger than the exterior width of the conduit;
the head has a second dimension that is a maximum separation distance between points on the outer edge that are on a line transverse to the first dimension;
the second dimension is not larger than an exterior width of the conduit;
a ratio of the first dimension to the second dimension is in a range of from 2 to 4;
the first dimension is in a range of from 2 to 10 millimeters;
the second dimension is in a range of from 1.5 millimeters to 4 millimeters;
a ratio of the first dimension to the second dimension is at least 1.5;
a proximal end at a first longitudinal end, the head being adjacent the proximal end;
a distal end at a second longitudinal end that is longitudinally opposite the first longitudinal end;
a conduit disposed between the head and the distal end, the internal passage extending through the head and the conduit;
a length longitudinally along the paranasal sinus access implant device between the proximal end and the distal end in a range of from 2 millimeters to 50 millimeters;
a width of the internal passage transverse to the length of the paranasal sinus access implant device in a range of from 0.25 millimeter to 5 millimeters;
the conduit including a first longitudinal portion and a second longitudinal portion located toward the distal end relative to the first longitudinal portion;
the first longitudinal portion of the conduit having a first minimum wall thickness adjacent the internal passage;
the second longitudinal portion of the conduit having a second minimum wall thickness adjacent the internal passage that is smaller than the first minimum wall thickness;
the first longitudinal portion of the conduit has a length of at least 5 millimeters;
the second longitudinal portion of the conduit has a length of at least 5 millimeters;
the second longitudinal portion of the conduit has a minimum exterior width at a location corresponding with the second minimum wall thickness;
the second longitudinal portion of the conduit has a maximum exterior width that is larger than the minimum exterior width of the second longitudinal portion of the conduit;
the first longitudinal portion of the conduit has a maximum exterior width that is smaller than the maximum exterior width of the second longitudinal portion of the conduit;
the first maximum exterior width and the first minimum exterior width are each within a range of from 1.5 millimeters to 2.5 millimeters;
the second maximum exterior width is in a range of from 1.6 millimeters to 3 millimeters;
the second minimum exterior width is in a range of from 1 millimeter to 2 millimeters;
the first minimum exterior width is at least 0.1 millimeter larger than the second minimum exterior width;
the second maximum exterior width is at least 0.2 millimeter larger than the first maximum exterior width;
an exterior of the second longitudinal portion of the conduit includes an anchoring surface feature including protrusion areas and recess areas, and wherein the second minimum wall thickness occurs at a location corresponding with at least one of the recess areas; and
the paranasal sinus access implant device is configured to be implanted between the lacrimal apparatus in the orbit and a paranasal sinus, wherein when so implanted:
the proximal end is disposed in the lacrimal apparatus within the orbit;
the distal end is disposed in the paranasal sinus; and
at least a portion of each of the first longitudinal portion and the second longitudinal portion of the conduit are disposed across tissue between the lacrimal apparatus in the orbit and the paranasal sinus and at least a portion of the second longitudinal portion of the conduit is disposed in the paranasal sinus.

### Claim 26 (depends on 24, 25)

An apparatus according to either one of claim 24 or claim 25, comprising a drug treatment composition disposed in the fluid container, wherein the drug treatment composition comprises at least two members selected from the group consisting of an antibiotic, a steroid, an anti-fungal, an anti-viral and an antihistamine.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

A kit, comprising:
a paranasal sinus access implant device configured to be implanted in a human to provide fluid access to a paranasal sinus, the paranasal sinus access implant device comprising:
a head configured to be disposed between the medial canthus and the medial side of an adjacent eyeball when the paranasal sinus access implant device is implanted; and
an internal passage providing fluid access through the paranasal sinus access implant device to a paranasal sinus when the paranasal sinus access implant device is implanted, the internal passage being accessible through an opening in the head;
a paranasal sinus fluid manipulation tool or components assemblable into the paranasal sinus fluid manipulation tool, the paranasal sinus fluid manipulation tool comprising:
a fluid container;
a paranasal sinus fluid connection engagement structure configured for insertion into the palpebral fissure for engagement with the head of the paranasal sinus access implant device when the paranasal sinus access implant device is implanted;
a fluid transmission structure configured to transmit fluid between the fluid container and the paranasal sinus access implant device when the paranasal sinus fluid connection engagement structure is in the engagement with the head of the paranasal sinus access implant device; and
the paranasal sinus access implant device and the paranasal sinus fluid manipulation tool being assembled or assemblable as the paranasal sinus fluid treatment apparatus of any one of claims 1-26 to perform at least one of the following fluid manipulations when the paranasal sinus fluid connection engagement structure is in the engagement with the head: (i) introducing fluid from the fluid container into the internal passage and (ii) applying suction to the internal passage for aspiration of fluid from the internal passage.

### Claim 28 (depends on 27)

A kit according to claim 27, comprising at least one cutting tool for cutting away tissue to form a fistula through which the implant device may be implanted during an implantation procedure, wherein the at least one cutting tool comprises a hollow member having a hollow cutting tip at a distal end of the cutting member configured to cut tissue to size the fistula for implantation of the implant device through the fistula.

### Claim 29 (depends on 27, 28)

A kit according to either one of claim 27 or claim 28, wherein the cutting member has a cutting width that is smaller than a maximum exterior width of a conduit of the implant device configured to be disposed through the fistula during implantation.

### Claim 30 (depends on 29)

A kit according to claim 29, wherein the maximum exterior width of the conduit of the implant device is in a range of from 2.0 to 2.75 millimeters;
the cutting width is not more than 0.75 millimeter smaller than the maximum exterior width of the conduit; and
the cutting width is in a range of from 1.5 millimeters to 2.5 millimeters.

### Claim 31 (depends on 27, 28, 29, 30)

A kit according to any one of claims 27-30, comprising a carrier tool for carrying the implant device during an implantation procedure, the carrier tool comprising:
a carrier member with a distal tip, the carrier member being adapted to be disposed through a fistula between the lacrimal apparatus in the orbit and a paranasal cavity with the distal tip located in the paranasal cavity; and
a hand-manipulable handle connected to the carrier member;
wherein:
the implant device is mountable on the carrier member for implantation with the mounted implant device disposed between the handle and the distal tip with the carrier member disposed through the internal passage and with a proximal end of the implant device disposed toward the handle and a distal end of the implant device disposed toward the distal tip of the member;
when the implant device is mounted for implantation, the carrier is disengageable from the implant device for implant placement of the implant device during an implantation procedure to provide fluid access to a paranasal sinus: and
a clearance fit of the carrier member in the internal passage when the implant device is mounted on the carrier member for implantation is no larger than 0.5 millimeter.
